Cargando…
Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes
BACKGROUND: In the Netherlands, a screening programme was set up in 1994 in order to identify all patients with familial hypercholesterolaemia (FH). After 15 years of screening, we evaluated the geographical distribution, possible founder effects and clinical phenotype of the 12 most prevalent FH ge...
Autores principales: | Kusters, D. M., Huijgen, R., Defesche, J. C., Vissers, M. N., Kindt, I., Hutten, B. A., Kastelein, J. J. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058324/ https://www.ncbi.nlm.nih.gov/pubmed/21475731 http://dx.doi.org/10.1007/s12471-011-0076-6 |
Ejemplares similares
-
Quality Assessment of the Genetic Test for Familial Hypercholesterolemia in The Netherlands
por: Kindt, Iris, et al.
Publicado: (2013) -
Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal
por: Huijgen, Roeland, et al.
Publicado: (2010) -
Recurrent and Founder Mutations in the Netherlands: the Long-QT Syndrome
por: Hofman, N., et al.
Publicado: (2010) -
Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D
por: van Spaendonck-Zwarts, K. Y., et al.
Publicado: (2012) -
Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy
por: van der Zwaag, P. A., et al.
Publicado: (2013)